Positioning no disclosures inside 60 days, left as found
Options put/call open interest 0.06, read 2026-11-05
Ethical passes the values gate
Price24.61 USD
Fair value21.09
Ethical score87.0/100
Value readOvervaluedas of 6 Nov 2026
Our investment reviews on this name
2026-10-25Read Markup23.68+3.9% to today ✓Markdown gives way to Markup first Markup read since August
2026-10-02Read Markdown23.56+4.5% to today Distribution gives way to Markdown after an 8% slide in 4 weeks
2026-09-03Read Distribution25.58-3.8% to today ✓Markup gives way to Distribution
2026-08-03Read Markup26.22-6.1% to today Accumulation gives way to Markup after a 16% rise in 5 weeks
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
Kraft Heinz holds its Markup at $24.61. Consolidating, no directional conviction, held for 6 days.
As held on the ledger · 2026-11-06
Phase
Markup
Quantitative state
Consolidating, no directional conviction, held for 6 days
Price at the screen
$24.61
Valuation
N/A trailing · 11.72 forward price to earnings
Values screen
PASS· score 87.0
Beta
0.11
The Workings
Five Screens, Shown in Full
Full pass across all five screens. This security clears the Titan Ethical Standard: its business and its balance sheet both stay inside the lines.
Test
Figure
Limit
What it means
Status
Business activity
Permissible
Core business clean
Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending.
Pass
Debt load
25.94%
Below 33%
Interest-bearing debt is just 25.9% of its assets, well under the one-third ceiling: it does not run on borrowed money.
Pass
Interest-bearing cash
1.30%
Below 33%
Cash held in interest-bearing accounts and securities is 1.3% of assets, under the one-third limit.
Pass
Receivables
5.95%
Below 49%
Money owed to the company is 6.0% of assets, under the 49% limit.
Pass
Revenue purity
0.49%
Below 5%
Only 0.5% of revenue comes from non-compliant sources, under the 5% line.
Pass
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical Read
Why It Clears, in Plain English
Kraft Heinz clears all five screens. Its business is in a permissible area, its interest-bearing debt is about 26%, inside the ~33% line, and almost none of its income is interest, so it passes.
Read as at 2026-11-07. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when KHC's ethical verdict changes
Today KHC passes the screen. If new figures move it to a fail, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
The quantitative screen above is arithmetic and this name passes it. Separately, community boycott lists cite this company: Cited in consumer boycott campaigns for food product manufacturing and distribution operations in Israel. The desk records that flag here without folding it into the verdict: the screen measures the balance sheet, the overlay informs the conscience, and they are different judgements that belong to different owners. The second one is yours.
What the Numbers Say It Is Worth
The Fair Value Range
Our analysis reads Overvalued vs our fair value, as of 6 Nov 2026: it trades above our $21.09 fair value estimate, weak competitive moat.
Fair value range in USD, drawn from the 2026-11-06 screen. The gold marker is the market price at the same screen. The price runs 16.7% above the base estimate.
Where our models see it going: fair-value estimate $21.09, with a range of $17.10 to $27.00, dated to the 2026-11-06 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
Familiar brands, fading numbers
Walk down any supermarket aisle and those red bottles and frozen trays still sit on the shelves like they always have. Yet revenue inches forward just 1 percent a year while profit margins sit at minus 23 percent and return on equity at minus 13 percent. A weak moat and shares priced 19 percent above fair value leave little to like despite the ethical screen clearing.
The 12.4 times forward earnings multiple looks ordinary until the weak growth and negative returns are factored in. Analysts see the same picture and cluster around a hold rating with a median target below the current price.
Another profit measure, before interest, tax and non-cash costs: EBITDA.
The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
KHC trades on a US exchange. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The Dated Journal · Newest First, Never Edited
Every Entry, As Written
2026-11-04Markup$24.52-1.6%Entry 17
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 1.6% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 4% above its long-term trend line with momentum reading overbought. Over the past year the shares are down 3%. Our forward projection puts the odds of a 10% gain over the next month near 8%. The street (19 analysts) rates it hold, with a mean price target of $24. It reported earnings in this window, a natural checkpoint for the thesis.
2026-11-03Markup$24.93+2.4%Entry 16
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 2.4% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 4% above its long-term trend line with momentum reading overbought. Over the past year the shares are down 3%. Our forward projection puts the odds of a 10% gain over the next month near 8%. The street (19 analysts) rates it hold, with a mean price target of $24. It reported earnings in this window, a natural checkpoint for the thesis.
2026-11-02Markup$24.34+0.0%Entry 15
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 4% above its long-term trend line with momentum reading overbought. Over the past year the shares are down 3%. Our forward projection puts the odds of a 10% gain over the next month near 8%. The street (19 analysts) rates it hold, with a mean price target of $24. It reported earnings in this window, a natural checkpoint for the thesis.
2026-11-01Markup$24.34+0.0%Entry 14
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 4% above its long-term trend line with momentum reading overbought. Over the past year the shares are down 3%. Our forward projection puts the odds of a 10% gain over the next month near 8%. The street (19 analysts) rates it hold, with a mean price target of $24. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-31Markup$24.34+1.8%Entry 13
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 1.8% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 4% above its long-term trend line with momentum reading overbought. Over the past year the shares are down 3%. Our forward projection puts the odds of a 10% gain over the next month near 8%. The street (19 analysts) rates it hold, with a mean price target of $24. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-30Markup$23.90+0.2%Entry 12
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 0.2% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 4% above its long-term trend line with momentum reading overbought. Over the past year the shares are down 3%. Our forward projection puts the odds of a 10% gain over the next month near 8%. The street (19 analysts) rates it hold, with a mean price target of $24. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-29Markup$23.86+0.8%Entry 11
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 0.8% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 4% above its long-term trend line with momentum reading overbought. Over the past year the shares are down 3%. Our forward projection puts the odds of a 10% gain over the next month near 8%. The street (19 analysts) rates it hold, with a mean price target of $24. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-28Markup$23.68+0.0%Entry 10
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 4% above its long-term trend line with momentum reading overbought. Over the past year the shares are down 3%. Our forward projection puts the odds of a 10% gain over the next month near 8%. The street (19 analysts) rates it hold, with a mean price target of $24. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-25Markup · changed$23.68+0.0%Entry 9
The framework has shifted from markdown to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 0% above its long-term trend line with momentum reading neutral. Over the past year the shares are down 3%. Our forward projection puts the odds of a 10% gain over the next month near 8%. The street (19 analysts) rates it hold, with a mean price target of $24.
2026-10-18Markdown$23.68+0.5%Entry 8
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved up 0.5% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 3%. Our forward projection puts the odds of a 10% gain over the next month near 8%. The street (19 analysts) rates it hold, with a mean price target of $24.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.